Significance of the Multi-gene Panel myRisk in Japan.
Hayashi S, Kubo M, Matsuzaki S, Kai M, Morisaki T, Yamada M, Kaneshiro K, Takao Y, Shimazaki A, Nagayoshi K, Mizuuchi Y, Nakamura M.
Hayashi S, et al. Among authors: shimazaki a.
Anticancer Res. 2022 Aug;42(8):4097-4102. doi: 10.21873/anticanres.15907.
Anticancer Res. 2022.
PMID: 35896222